|
 |
European Pharmaceutical Contractor
|
Treatment and Benefits of Hyperbaric Oxygen Therapy
HBO therapy is the provision of oxygen at raised pressure. Oxygen (O2) behaves like a drug with response depending on the dose:
Air at 1 atmosphere gives a dose of 0.2 bar O2
100 per cent oxygen at 1 atmosphere gives a dose of 1 bar O2
100 per cent oxygen at 2.8 bar gives a dose of 2.8 bar O2 (that is 14 times the dose of O2 compared with air at 1 atmosphere)
Patients breathe the oxygen via a mask, hood or ventilator at pressures above 1 atmosphere (bar) and are treated in a recompression chamber, where they are accompanied by a doctor, nurse or attendant. The pressure in the chamber is raised with compressed air. The attendants will therefore breathe this air for most of the treatment duration, and at designated times they will have to breathe oxygen which lowers the risk of decompression illness.
Patients will receive between two and 40 treatments depending on the medical condition being treated. Typically patients with decompression illness or carbon monoxide poisoning may only require between one and three treatment sessions, while patients with difficult wounds may require up to 40. The pressure in the chamber is raised to between 2.4 and 2.8 bar, and each treatment will last from two to eight hours, again depending on the medical condition.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
FT Global Pharmaceutical and Biotechnology Conference 2008
2-3 December 2008, The Cumberland, London
FT Global Pharmaceutical and Biotechnology Conference is Europe’s pre-eminent industry event attended by leading executives, government decision makers, investors, analysts and other specialist providers. It provides a unique platform to present new perspectives,’ feel the pulse’ of the industry, and network with peers across the sector.
More info >> |
|
 |
News and Press Releases |
 |
INTERLAB growing at a rate of 35%
24th November 2008
More info >> |
|
 |
